Glipizide
- Product NDC
- 63629-4071
- 11-digit product format
- 636294071
- Labeler code
- 63629
- Product ID
- 63629-4071_92366bf9-30e6-4f7e-b7bc-1787d5852d75
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076467
- Marketing category
- ANDA
- Marketing start
- 2003-11-19
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63629-4071-1 | 2021-08-17 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-2 | 2021-08-17 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-3 | 2021-08-17 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-4 | 2021-08-17 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |
| 63629-4071-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-63a9-f424-e053-dadaa90a57ce | 760d589c-24f1-c89a-bc01-ea57101b2f20 |